Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis

Allergy and Asthma Proceedings

Volumn 31, Issue 1, 2010, Pages 68-75

  Katial, Rohit K ^a   Oppenheimer, John J ^b   Ostrom, Nancy K ^c   Mosnaim, Giselle S ^d   Yancey, Steven W ^e   Waitkus Edwards, Kelli R ^e   Prillaman, Barbara A ^e   Ortega, Hector G ^e  

^a DEPARTMENT OF MEDICINE   (United States)

^b Pulmonary and Allergy Associates PA   (United States)

^c Asthma and Allergy Research Group and Medical Center   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

Allergic rhinitis; Asthma; Fluticasone propionate; Inhaled corticosteroids; Leukotriene receptor antagonists; Long acting beta agonists; Montelukast; Nasal symptom scores; Salmeterol; Symptoms

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST;

ADD ON THERAPY; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG USE; DRUG WITHDRAWAL; EMERGENCY CARE; FEMALE; HAY FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODERATE PERSISTENT ASTHMA; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACETATES; ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ADULT; ALBUTEROL; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUINOLINES; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76149136399     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3306     Document Type: Article

References (31)

1. Greisner W, Settipane R, and Settipane G. Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy Asthma Proc 19:185-188, 1998.
2. Guerra S, Sherrill D, Martinex F, and Barbee R. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 109:419-425, 2002.
3. Yawn B, Yunginger J, Wollan P, et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: Frequency and impact on health care charges. J Allergy Clin Immunol 103:54-59, 1999.
4. Bousquet J, van Cauwenberge P, Khaltaev N, and Lund VJ. World Health Organisation initiative on allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:S147-S336, 2001.
5. Palma-Carlos AG, Branco-Ferreira M, and Palma-Carlos ML. Allergic rhinitis and asthma: More similarities than differences. Allerg Immunol (Paris) 33:237-241, 2001.
6. Watson W, Becker A, and Simons F. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness. J Allergy Clin Immunol 91:97-101, 1993.
7. Foresi A, Pelucchi A, Gherson G, et al. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 98:274-282, 1996.
8. Thomas M. Allergic rhinitis: Evidence for impact on asthma. BMC Pulm Med 6(suppl 1):54, 2006.
9. Corren J. The connection between allergic and bronchial asthma. Cur Opin Pulmon Med 13:13-18, 2007.
10. Crystal-Peters J, Neslusan C, Crown W, et al. Treating allergic rhinitis in patients with comorbid asthma: The risk of asthmarelated hospitalization and emergency department visits. J Allergy Clin Immunol 109:57-62, 2002.
11. Kavuru M, Melamed J, Gross G, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 105:1108 -1116, 2000.
12. Weiner J, Abramson M, and Puy R. Intranasal corticosteroids versus oral H1 receptor antagonist in allergic rhinitis: Systemic review of randomised controlled trials. BMJ 317:219-224, 1998.
13. Stempel DA, and Thomas M. Treatment of allergic rhinitis: An evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines. Am J Manag Care 4:89-96, 1998.
14. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000.
15. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Expert Panel Report III, National Institutes of Health publication 07-4051, National Heart, Lung, and Blood Institute, Bethesda, MD, 2007.
16. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) 2007. Available online at www. ginasthma.org; accessed May 18, 2009.
17. Philip G, Malmstrom K, Hampel F, et al. Montelukast for treating seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 32:1020-1028, 2002.
18. Flowers B, Proud D, Kagey-Sobotka A, et al. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg 102:219-224, 1990.
19. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-244, 1987.
20. Hankinson J, Odencantz J, and Fedan K. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179-187, 1999.
21. Fod and Drug Administration (FDA) Draft Guidance for Industry. Allergic rhinitis: Clinical development programs for drug products. Available online at www.fda.gov; assessed May 22, 2009.
22. Nathan R, Yancey S, Waitkus-Edwards K, et al. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 128: 1910-1920, 2005.
23. Fuhlbrigge A, Reed ML, Stempel DA, et al. The status of asthma control in the US adult population. Allergy Asthma Proc 30: 529-533, 2009.
24. Pullerits T, Praks L, Ristioja V, and Lö tvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 109:949-955, 2002.
25. Bateman ED, Boushey HA, Bousquet J, et al. Can guidelinedefined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Crit Care Med 170:836-844, 2004.
26. Pearlman DS, White MV, Lieberman AK, et al. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Ann Allergy Asthma Immunol 88:227-235, 2002.
27. Weiss K, and Sullivan D. The health economics of asthma and rhinitis: Assessing the economic. J Allergy Clin Immunol 107: 3-8, 2001.
28. Adams R, Fuhlbrigge A, Finkelstein J, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 109:636-642, 2002.
29. Stempel D, and Woolf R. The cost of treating allergic rhinitis. Curr Allergy Asthma Rep 2:223-230, 2002.
30. Stelmach R, and Cukier A. Treating allergic rhinitis and asthma: Different sides of the same fence. Expert Opin Pharmacother 7:1245-1249, 2006.
31. Sheth K, Cook C, Philpot E, et al. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic -pituitary-adrenal-axis function. Allergy Asthma Proc 25:115-120, 2004.